Related Experiment Videos
An alpha-1,3-mannosyltransferase of Cryptococcus neoformans
Ulf Sommer1, Hong Liu, Tamara L Doering
1Department of Molecular Microbiology, Washington University Medical School, St. Louis, Missouri 63110, USA.
The Journal of Biological Chemistry
|September 25, 2003
Summary
Researchers identified cryptococcal mannosyltransferase 1 (CMT1), an enzyme crucial for synthesizing the fungal pathogen Cryptococcus neoformans's capsule. Disrupting CMT1 reduced capsule formation but did not affect virulence in animal models.
Area of Science:
- Mycology
- Biochemistry
- Molecular Biology
Background:
- Cryptococcus neoformans possesses a polysaccharide capsule essential for virulence.
- Understanding the biosynthesis of this capsule is key to developing antifungal strategies.
Purpose of the Study:
- To identify and characterize the alpha-1,3-mannosyltransferase responsible for synthesizing the glucuronoxylomannan capsule.
- To elucidate the role of this enzyme in capsule formation and fungal pathogenesis.
Main Methods:
- Purification of alpha-1,3-mannosyltransferase activity from C. neoformans.
- Analysis of enriched protein fractions using sequence information and RNA interference.
- Cloning and expression of the candidate gene (CMT1) in Saccharomyces cerevisiae.
- Generation of a CMT1 knockout strain in C. neoformans.
Main Results:
- A 46 kDa protein, encoded by CMT1, was identified as the alpha-1,3-mannosyltransferase.
- RNA interference targeting CMT1 abolished mannosyltransferase activity and reduced capsule formation.
- CMT1 is homologous to previously identified cryptococcal genes (CAP59, CAP64) involved in capsule synthesis.
- Disruption of CMT1 in C. neoformans did not affect virulence in a murine model.
Conclusions:
- CMT1 encodes a key enzyme in the biosynthesis of the Cryptococcus neoformans capsule.
- While essential for capsule formation, CMT1's role in virulence appears complex and may be compensated for by other factors.